A 54-year-old male patient with known 2-vessel coronary artery disease and stable angina presented for elective percutaneous coronary intervention of a proximal right coronary artery stenosis (Figure 1) . Previously, the patient had undergone intervention of mid-left anterior descending coronary artery stenosis by sirolimus-eluting stent implantation.
Within the scope of the first-in-human clinical trial (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents [PROGRESS-AMS]), the patient was treated by implantation of an absorbable metal stent (Biotronik; Figure 2 ). This novel stent consists of a magnesium-based alloy that provides mechanical properties comparable to those of conventional stainless steel stents. At the same time, the magnesium alloy allows controlled complete biodegradation (reabsorption) within approximately 2 months. Because of its composition of Ͼ90% magnesium, the stent is completely radiolucent and cannot be visualized by x-ray. This requires the use of intravascular ultrasound to evaluate the postinterventional stent expansion (Figure 3) . However, because the stent also does not exert metallic artifacts, it has potential for noninvasive follow-up by MRI (Figure 4) . 
